Court Awards Whistleblower $820,000

A jury finds that UVA wrongfully fired a researcher for reporting that his supervisor altered an NIH grant budget.

Written byBeth Marie Mole
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

University of Virginia, Wikimedia, terren in VirginiaA federal court awarded Weihua Huang, a former University of Virginia geneticist, more than $800,000 last week after a jury found that the university wrongfully fired him for telling officials that his supervisor, Ming Li, had surreptitiously changed the budget for Huang’s grant—inappropriately increasing the amount of funding—provided by the National Institutes of Health.

“This decision is important to the entire grant community because, on these grants, levels of efforts are assigned and the principal investigator is responsible for the use of the money,” Adam Carter, Huang's attorney, told the Richmond-Times Dispatch. “That is the person who needs to be responsible and, in this case, that responsibility was taken over by the lab director.”

As a principle investigator, Huang applied for and received a NIH grant of $378,750 in 2008 to study the genetics of nicotine addiction. According to the suit, Huang had originally budgeted 50 percent of his time to the project and 5 percent of Li’s time, but later realized that Li had changed the budget without consulting him—bumping Huang’s commitment to 75 percent, Li’s to 7.5 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies